Picton Mahoney Asset Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Picton Mahoney Asset Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,000	Closed	-$400K	–	758
2022 Q3	$400K	Hold	40,000	–	–	0.01%	488
2022 Q2	$395K	Hold	40,000	–	–	0.02%	586
2022 Q1	$394K	Hold	40,000	–	–	0.01%	631
2021 Q4	$390K	Hold	40,000	–	–	0.01%	667
2021 Q3	$392K	Buy	+40,000	New	+$388K	0.01%	588

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Picton Mahoney Asset Management's PKBO Position: Q4 2022 in Review

Picton Mahoney Asset Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 40,000 shares — an estimated $400K sold.

Picton Mahoney Asset Management first reported a position in PKBO in Q3 2021 and held it in 5 quarters. The position peaked at $400K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Picton Mahoney Asset Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 40,000 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $400K.
Picton Mahoney Asset Management first reported a position in Peak Bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Picton Mahoney Asset Management's Peak Bio, Inc. Common Stock position peaked at $400K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.